(Q30277016)

17 August 2017

Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk (English)

1 reference

Aleksandra Gentry-Maharaj

17 August 2017

1 reference

12

0 references

Francesmary Modugno

14

0 references

Jenny Chang-Claude

6

0 references

Allan Jensen

Allan Jensen

19

0 references

Susan J. Ramus

Susan J Ramus

29

0 references

Usha Menon

Usha Menon

8

0 references

Joellen M Schildkraut

5

Joellen M Schildkraut

1 reference

17 August 2017

23

Anja Rudolph

1 reference

17 August 2017

18

Mary Anne Rossing

1 reference

17 August 2017

2

Roberta B Ness

1 reference

17 August 2017

32

Celeste Leigh Pearce

1 reference

17 August 2017

16

Kirsten B Moysich

1 reference

17 August 2017

4

Kathryn L Terry

1 reference

17 August 2017

10

Simon A Gayther

1 reference

17 August 2017

Kara L. Cushing-Haugen

21

Kara L Cushing-Haugen

1 reference

17 August 2017

20

Kristine G Wicklund

1 reference

17 August 2017

7

Jennifer A Doherty

1 reference

17 August 2017

30

Anna H Wu

1 reference

17 August 2017

3

Lynda D Roman

1 reference

17 August 2017

17

Andrew Berchuck

1 reference

17 August 2017

27

Michael E Carney

1 reference

17 August 2017

11

Harvey Risch

1 reference

17 August 2017

9

Daniel W Cramer

1 reference

17 August 2017

22

Estrid Hogdall

1 reference

17 August 2017

26

Susanne K Kjaer

1 reference

17 August 2017

31

Malcolm C Pike

1 reference

17 August 2017

13

Marc T Goodman

1 reference

17 August 2017

28

Daniel O Stram

1 reference

17 August 2017

25

Lynne R Wilkens

1 reference

17 August 2017

24

Pamela J Thompson

1 reference

17 August 2017

Alice W Lee

1

1 reference

17 August 2017

Ursula Eilber

15

1 reference

17 August 2017

Ovarian Cancer Association Consortium

33

1 reference

17 August 2017

language of work or name

English

0 references

publication date

4 April 2016

1 reference

Obstetrics and Gynecology

17 August 2017

1 reference

17 August 2017

127

1 reference

17 August 2017

5

1 reference

17 August 2017

828-836

1 reference

Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

17β-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Sun exposure and risk of epithelial ovarian cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Hormone therapy and ovarian cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Markers of inflammation and risk of ovarian cancer in Los Angeles County

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio Osteoporosis Risk Factor and Prevention Study .

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Ovarian cancer and hormone replacement therapy in the Million Women Study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

A prospective study of postmenopausal hormone use and ovarian cancer risk

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Endometrial cancer and hormone-replacement therapy in the Million Women Study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Estrogen, progesterone and epithelial ovarian cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Cyclic changes in ciliation, cell height, and mitotic activity in human tubal epithelium during reproductive life

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation status.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Comparison of patient recall of hormone therapy with physician records

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

PGR +331 A/G and increased risk of epithelial ovarian cancer

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Low-dose oral contraceptives: protective effect on ovarian cancer risk

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4892111

Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen

26 November 2018

1 reference

12 December 2020

Hormone replacement therapy and ovarian cancer risk: a meta-analysis

1 reference

12 December 2020

International variability in ages at menarche, first livebirth, and menopause. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives

1 reference

12 December 2020

Menopausal hormones and risk of ovarian cancer

1 reference

12 December 2020

10.1097/AOG.0000000000001387

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

1 reference